Important note: Information in this article was accurate in September 2006. The state of the art may have changed since the publication date.
Other resources
HIV Treat Bull - Vol. 7, No. 7/8, September 2006
Resource for HIV-positive travelers:
As a resource for HIV-positive travelers, the German AIDS Federation and International Lesbian and Gay Association, have published an online overview of travel and entry restrictions in different countries: ‘Quick Reference: Travel and Residence Regulations for People with HIV and AIDS 2005’.
The regulations and restrictions for people with HIV/AIDS can be drastically different from country to country, and the guide is being updated as quickly as possible to reflect these changes. The latest edition reflects the most up-to-date information available in 2005, and a new version of the survey is tentatively slated for publication after the summer of 2007.
Nonetheless, some notable policy changes have already occurred including positive changes in Canadian entry policy, introduced to support delegates attending the IAS conference in Toronto this summer. Canada does not now require people applying for a visa to enter Canada as a short term visitor to disclose known HIV infection, does not routinely impose mandatory HIV testing on short-term visitors, nor does it categorically bar visitors based on their HIV-positive status.
Other updated information is available in
Updates in English are available at:
If you have any comments or information about individual countries, please contact Peter Wiesser at: peter-wiessner@tonline.de.
Policy surrounding HIV/AIDS can be ambiguous or politically volatile, and it may be wise to compare information from a variety of sources before traveling abroad.
2006-09-10
IB060709-08
©2008. I-BASE HIV Treatment Bulletin. Permission to reproduce courtesy of HIV i-Base, Third Floor East, Thrale House, 44-46 Southwark Street, London SE1 1UN - T: +44 (0) 20 7407 8488 F: +44 (0) 20 7407 8489
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted grants from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 2008. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2008. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content.